# Retrospective Real World Oxbryta® Data Collection and Analysis Study

> **NCT04930328** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 216 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Oxbryta® (voxelotor) 500-mg Tablets

## Key facts

- **NCT ID:** NCT04930328
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-20
- **Primary completion:** 2022-02-25
- **Final completion:** 2022-02-25
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04930328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04930328, "Retrospective Real World Oxbryta® Data Collection and Analysis Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04930328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*